Search Results 341-350 of 838 for ‼불법키워드대행 [ 텔레 : SEOGOT ] 구글1페이지광고업체 찌라시마케팅대행업체 찌라시마케팅전문 찌라시마케팅광고업체 찌라시마케팅대행업체 찌라시마케팅홍보‼

  1. A Study of the Delivery of Yamani-15/5 Chemical Solution for Peripheral Artery Disease - Mayo Clinic

    About this study. This is a feasibility study to evaluate the impact of local delivery of Yamani-15/5 (combination of L-Lactic acid 15% and D-Gluconic acid ...

  2. A Study of the Safety and Effectiveness of ADS-5102 in Patients with Multiple Sclerosis and a Walking Impairment - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  3. Laboratories - Mayo Clinic Research

    O. Orthopedic Biomechanics Research · Orthopedic Genetic Host Variation: Matthew P. Abdel · Orthopedic Surgery Artificial Intelligence Laboratory: Cody C.

  4. A Natural History Study of Moderate Adolescent Idiopathic Scoliosis in Mature Patients - Mayo Clinic

    The purpose of this study is to define the risk of continued curve progression for patients with adolescent idiopathic scoliosis (AIS) after skeletal maturity.

  5. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis - Mayo Clinic

    The primary hypothesis of the study is that treatment with pacritinib results in a greater proportion of patients achieving ≥ 35% reduction in spleen volume ...

  6. Stress Echocardiography in Mixed and Multi Valvular Heart Disease - Mayo Clinic

    About this study. The purpose of this study is to: investigate the diagnostic utility of stress echocardiography (SE) in the evaluation of patients with ...

  7. Early Life Adversity and Neighborhood Environment with Traumatic Brain Injury Outcomes - Mayo Clinic

    ... 1-year traumatic brain injury (TBI) outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  8. A Study to Determine How Corneal Transparency is Affected in Fuchs Dystrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

    GVHD is the most common serious complication, after bone marrow transplant. GVHD occurs when the donor cells (the graft), treat the recipient's body as "foreign ...

  10. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.